NEW YORK (GenomeWeb News) — The National Institute of Mental Health plans to grant around $2 million to investigators who are studying ways to apply pharmacogenomics and personalized medicine technologies and techniques to the treatment of depression, the National Institutes of Health announced last week.
 
The goal of the project, which will support around seven researchers for up to three years, is to test new approaches and to develop models that will integrate specific patient characteristics into the treatment of depression.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.